Keyphrases
Low Ejection Fraction
95%
Coronary Artery Bypass Graft Surgery
91%
Cardiac Function
73%
CD133
68%
Ejection Fraction
57%
Coronary Artery Bypass Grafting
54%
Indonesia
49%
Ischemic Heart Disease
48%
Bone Marrow Cells
45%
Stem Cell Therapy
45%
Clinical Outcomes
37%
Clinical Trials
35%
Older Men
34%
Cardiac Surgery
31%
Cardiac Surgery Patients
30%
Meta-analysis
29%
Cardiac Magnetic Resonance Imaging (cMRI)
29%
Mitral Valve Repair
28%
Heart Center
26%
Left Ventricular Ejection Fraction
26%
Stem Cell Transplantation
26%
Meta-analysis of Randomized Controlled Trials
26%
Randomized Controlled Trial
26%
Myocardial Infarction
24%
Treatment Group
24%
Superior Vena Cava
22%
Transseptal
22%
Epithelial Stem Cells
22%
Functional Exercise Capacity
22%
Early Myocardial Infarction
22%
Capacity Enhancement
22%
Heart Model
22%
Bypass Grafting
22%
Porcine Heart
22%
Giant Lipoma
22%
Perioperative nursing
22%
Hypnosis
22%
Cell Sheet Transplantation
22%
IMSCs
22%
Pain-related Fear
22%
Intramyocardial
22%
Myocardial Regeneration
22%
Collagen Type 1
22%
Gerbode Defect
22%
Exercise Therapy
22%
Human Cardiomyocytes
22%
NewHope
22%
Collagen III
22%
Nursing Intervention
22%
Vascular Endothelial Growth Factor
22%
Medicine and Dentistry
Ejection Fraction
100%
Heart Function
82%
Coronary Artery Bypass Graft
60%
Randomized Controlled Trial
51%
Stem Cell
50%
Coronary Artery Bypass Surgery
45%
Meta-Analysis
45%
Coronary Artery Bypass Graft Surgery
45%
Stem Cell Therapy
45%
Systematic Review
40%
Ischemic Heart Disease
36%
Clinical Trial
29%
Heart Left Ventricle Ejection Fraction
29%
Cardiac Magnetic Resonance Imaging
28%
Revascularization
28%
Mitral Insufficiency
27%
Hematopoietic Cell
26%
Regeneration
26%
Heart Surgery
25%
Congestive Heart Failure
24%
Superior Vena Cava
22%
Lipoma
22%
Cardiac Muscle Cell
22%
off Pump Coronary Surgery
22%
Persistent Truncus Arteriosus
22%
Amnion
22%
Hope
22%
Dexamethasone
22%
Severe Acute Respiratory Syndrome Coronavirus 2
22%
COVID-19
22%
Fatality
22%
Infection
22%
Randomized Clinical Trial
22%
Mitral Valve Replacement
22%
Thrombocytopenic Purpura
22%
Island Flap
22%
Graft Patency
22%
Saphenous Vein Graft
22%
Bone Marrow Cell
22%
Idiopathic Thrombocytopenic Purpura
22%
Platelet
22%
Myxoma
22%
Thrombocyte Concentrate
22%
Bone Wax
22%
Vasculotropin
22%
Therapy Effect
22%
Sternum
22%
Right Atrium
19%
New York Heart Association Class
17%
Attributable Risk
17%